Company Profiles

driven by the PitchBook Platform

Anergis

Description

Provider of disease-modifying allergy immunotherapy services. The company develops allergy vaccines which aims at offering patients a long-term cure from allergies and reduce the treatment time.

2001

Founded

PRIVATE

Status

11-50

Employees

Series B

Latest Deal Type

$31.1M

Latest Deal Amount

$53.7M

Total Amount Raised

Description

Provider of disease-modifying allergy immunotherapy services. The company develops allergy vaccines which aims at offering patients a long-term cure from allergies and reduce the treatment time.

Website:

www.anergis.ch

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

Biopôle III Route de la Corniche 9B 1066 ÉpalingesSwitzerland +41 (0)21 651 9220
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Anergis's full profile, request a free trial.

Anergis Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Anergis Investors (8)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
BioMedPartnersVenture CapitalMinority000 0000000 0000
BlueOcean VenturesVenture CapitalMinority000 0000000 0000
DEFI GestionPE/BuyoutMinority000 0000000 0000
Esperante VenturesVenture CapitalMinority000 0000000 0000
Renaissance KMU Schweizerische AnlagestiftungPE/BuyoutMinority000 0000000 0000
BioMedPartners Venture Capital
BlueOcean Ventures Venture Capital
DEFI Gestion PE/Buyout
Esperante Ventures Venture Capital
Renaissance KMU Schweizerische Anlagestiftung PE/Buyout

Anergis Executive Team (7)

NameTitleBoard
Seat
Contact
Info
Vincent Charlon Ph.DChief Executive Officer
Zoltán CziglerChief Financial Officer
Kim SimonsenChief Development Officer
Christophe Reymond Ph.DChief Scientific Officer
Gerard Farmer Ph.DDirector, Regulatory Affairs
Vincent Charlon Ph.D Chief Executive Officer
Zoltán Czigler Chief Financial Officer
Kim Simonsen Chief Development Officer
Christophe Reymond Ph.D Chief Scientific Officer
Gerard Farmer Ph.D Director, Regulatory Affairs

Anergis Board Members (7)

NameRepresentingRoleSinceContact
Info
Claude SuardDEFI GestionChief Financial Officer & Partner000 0000
Dino Dina MDSelfBoard Member000 0000
Francois Spertini MDAnergisFounder, Chairman of Scientific Advisory Board & Vice Chairman000 0000
Jacques-François MartinSelfChairman000 0000
Klaus Schollmeier Ph.DSelfChairman000 0000
Claude Suard Chief Financial Officer & Partner DEFI Gestion
Dino Dina MD Board Member Self
Francois Spertini MD Founder, Chairman of Scientific Advisory Board & Vice Chairman Anergis
Jacques-François Martin Chairman Self
Klaus Schollmeier Ph.D Chairman Self
Request full access to PitchBook